Tag: strategy

ALBUQUERQUE, New Mexico, July 16, 2025 (GLOBE NEWSWIRE) -- As the medical aesthetics industry continues to experience exponential growth, many medspa owners and aesthetic providers find themselves overwhelmed — juggling clients, marketing, operations, and still struggling to generate consistent profits. Dr. Kalpana Sundar, a board-certified physician and nationally recognized aesthetic business strategist, is on a mission to change that. This August, she is bringing her signature Aesthetic Profit Accelerator Bootcamp to Albuquerque, New Mexico, from August 7–10, 2025 — a powerful four-day intensive seminar designed to help aesthetic professionals turn passion into predictable, scalable profit.

Transaction brings total financing commitments across Alterra’s fully discretionary IOS funds to over $1.5 billion

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," “Aptorum” or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs in oncology  and infectious diseases, and DiamiR Biosciences (“DiamiR”), a developer of proprietary innovative blood-based tests for brain health and other diseases with a CLIA licensed, CAP accredited clinical laboratory in New Haven, CT, today announced that they have entered into a definitive agreement for an all-stock merger transaction, in which DiamiR Biosciences will retain its name and become a wholly-owned subsidiary of Aptorum Group upon consummation of the merger.The combined company expects to remain listed on the Nasdaq Stock Market following the closing of the merger.